DE60126760T2 - Vektorkonstrukte - Google Patents

Vektorkonstrukte Download PDF

Info

Publication number
DE60126760T2
DE60126760T2 DE60126760T DE60126760T DE60126760T2 DE 60126760 T2 DE60126760 T2 DE 60126760T2 DE 60126760 T DE60126760 T DE 60126760T DE 60126760 T DE60126760 T DE 60126760T DE 60126760 T2 DE60126760 T2 DE 60126760T2
Authority
DE
Germany
Prior art keywords
promoter
use according
transcription terminator
nucleotides
downstream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126760T
Other languages
German (de)
English (en)
Other versions
DE60126760D1 (de
Inventor
Geert Plaetinck
Jean-Pierre Renard
Thierry Bogaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9891999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60126760(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Devgen NV filed Critical Devgen NV
Application granted granted Critical
Publication of DE60126760D1 publication Critical patent/DE60126760D1/de
Publication of DE60126760T2 publication Critical patent/DE60126760T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Optical Communication System (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Control Of Ac Motors In General (AREA)
  • Soft Magnetic Materials (AREA)
DE60126760T 2000-05-19 2001-05-18 Vektorkonstrukte Expired - Lifetime DE60126760T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0012233.3A GB0012233D0 (en) 2000-05-19 2000-05-19 Vector constructs
GB0012233 2000-05-19
PCT/IB2001/001068 WO2001088121A1 (en) 2000-05-19 2001-05-18 Vector constructs

Publications (2)

Publication Number Publication Date
DE60126760D1 DE60126760D1 (de) 2007-04-05
DE60126760T2 true DE60126760T2 (de) 2007-11-15

Family

ID=9891999

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60126760T Expired - Lifetime DE60126760T2 (de) 2000-05-19 2001-05-18 Vektorkonstrukte
DE60143718T Expired - Lifetime DE60143718D1 (de) 2000-05-19 2001-05-18 Vektorkonstruktionen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60143718T Expired - Lifetime DE60143718D1 (de) 2000-05-19 2001-05-18 Vektorkonstruktionen

Country Status (9)

Country Link
US (2) US7358069B2 (enExample)
EP (2) EP1285062B1 (enExample)
JP (2) JP5153983B2 (enExample)
AT (2) ATE354652T1 (enExample)
AU (1) AU2001264166A1 (enExample)
DE (2) DE60126760T2 (enExample)
ES (2) ES2356389T3 (enExample)
GB (2) GB0012233D0 (enExample)
WO (1) WO2001088121A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs
US7612194B2 (en) * 2001-07-24 2009-11-03 Monsanto Technology Llc Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
US20040180438A1 (en) 2002-04-26 2004-09-16 Pachuk Catherine J. Methods and compositions for silencing genes without inducing toxicity
AU2003239851A1 (en) * 2002-05-08 2003-11-11 Xantos Biomedicine Ag Expression constructs for producing double-stranded (ds) rna and the use thereof
US20040121353A1 (en) 2002-05-23 2004-06-24 Ceptyr, Inc. Modulation of TCPTP signal transduction by RNA interference
MXPA04011624A (es) 2002-05-24 2005-03-07 Schering Corp Anticuerpo neutralizante humano anti-igfr.
WO2004001044A1 (en) * 2002-06-21 2003-12-31 Sinogenomax Company Ltd. Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
US20050196862A1 (en) * 2002-08-30 2005-09-08 Wooddell Christine I. DNA cassette for cellular expression of small RNA
EP1694850B1 (en) 2003-11-12 2011-06-29 Schering Corporation Plasmid system for multigene expression
AR046639A1 (es) 2003-11-21 2005-12-14 Schering Corp Combinaciones terapeuticas de anticuerpo anti- igfr1
ES2547381T3 (es) 2004-04-09 2015-10-05 Monsanto Technology, Llc Composiciones y procedimientos de control de infestaciones de insectos en plantas
PL2444497T3 (pl) * 2004-09-24 2015-04-30 Simplot Co J R Wyciszanie genów
NZ582988A (en) 2004-10-21 2011-07-29 Venganza Inc Methods and materials for conferring resistance to pests and pathogens of plants
EP1807520B1 (en) 2004-10-25 2012-07-25 Devgen NV Rna constructs
US20060242736A1 (en) 2004-12-23 2006-10-26 Shihshieh Huang Dissimilar promoters for gene suppression
CA2610644A1 (en) 2005-05-31 2006-12-07 Devgen Nv Rnai for control of insects and arachnids
CA2622660C (en) 2005-09-16 2017-11-07 Devgen Nv Transgenic plant-based methods for plant pests using rnai
BRPI0616181B1 (pt) 2005-09-16 2024-03-05 Monsanto Technology Llc Construção de polinucleotídeo isolada, sequência de ribonucleotídeo de fita dupla, microrganismo transgênico, seu método de produção, e métodos para controle de infestação por coleóptero praga, para melhorar o rendimento e a tolerância a estiagem de um cultivo, e para produção de um produto comercial, alimento ou ração
BRPI0615792A2 (pt) 2005-09-16 2009-06-16 Devgen Nv métodos de controle de pestes com base no uso de rnai
EP1971688B1 (en) 2006-01-12 2012-03-14 Devgen NV Dsrna as insect control agent
US8906876B2 (en) 2006-01-12 2014-12-09 Devgen Nv Methods for controlling pests using RNAi
EP2348115A3 (en) 2006-01-12 2012-01-18 deVGen N.V. Transgenic plant-based methods for plant pests using RNAi
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
AU2011322510B2 (en) 2010-10-27 2016-05-05 Devgen Nv Down-regulating gene expression in insect pests
WO2013071047A1 (en) * 2011-11-11 2013-05-16 Children's Medical Center Corporation Compositions and methods for in vitro transcription of rna
EP3938518A4 (en) 2019-03-12 2023-01-11 Terra Bioworks, Inc. EXPRESSION VECTOR
WO2022011082A1 (en) * 2020-07-08 2022-01-13 Stellate Biotherapeutics, Inc. Compositions and methods for producing single stranded dna

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
US5017488A (en) * 1986-04-01 1991-05-21 University Of Medicine And Dentistry Of New Jersey Highly efficient dual T7/T3 promoter vector PJKF16 and dual SP6/T3 promoter vector PJFK15
US5955363A (en) * 1990-01-03 1999-09-21 Promega Corporation Vector for in vitro mutagenesis and use thereof
EP0738779B1 (en) 1990-09-27 2004-05-19 Invitrogen Corporation Direct cloning of PCR amplified nucleic acids
WO1993016170A1 (en) * 1992-02-06 1993-08-19 Gil Ho Choi Genetically engineered transmissible hypovirulence
EP1036846A3 (en) * 1994-02-28 2000-10-18 Shimadzu Corporation Oligonucleotides for detecting bacteria and detection process
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
ATE312934T1 (de) * 1995-06-07 2005-12-15 Univ Washington Rekombinant bakterielle system mit umweltbeschränkte lebensfähigkeit
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
FR2782325B1 (fr) * 1998-08-12 2002-05-24 Proteus Procede d'identification de sequences polynucleotidiques et/ou des proteines correspondantes a partir d'un echantillon d'acides nucleiques
GB9827152D0 (en) * 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
GB0012233D0 (en) * 2000-05-19 2000-07-12 Devgen Nv Vector constructs

Also Published As

Publication number Publication date
US7358069B2 (en) 2008-04-15
GB0012233D0 (en) 2000-07-12
EP1775345B1 (en) 2010-12-22
EP1285062B1 (en) 2007-02-21
GB2365867A (en) 2002-02-27
GB2365867B (en) 2002-08-14
EP1775345A3 (en) 2007-09-05
EP1285062A1 (en) 2003-02-26
JP2012228256A (ja) 2012-11-22
EP1775345A2 (en) 2007-04-18
DE60126760D1 (de) 2007-04-05
JP5153983B2 (ja) 2013-02-27
JP5645886B2 (ja) 2014-12-24
ATE492638T1 (de) 2011-01-15
AU2001264166A1 (en) 2001-11-26
US7932062B2 (en) 2011-04-26
DE60143718D1 (de) 2011-02-03
JP2004524804A (ja) 2004-08-19
ATE354652T1 (de) 2007-03-15
WO2001088121A1 (en) 2001-11-22
ES2356389T3 (es) 2011-04-07
US20040166580A1 (en) 2004-08-26
GB0112213D0 (en) 2001-07-11
US20080241894A1 (en) 2008-10-02
ES2281420T3 (es) 2007-10-01

Similar Documents

Publication Publication Date Title
EP1775345B1 (en) Vector constructs
DE3689802T2 (de) "Hervorrufung somatischer Veränderungen in Pflanzen durch Verwendung von minussträngigen RNAs".
DE69517105T2 (de) In vitro transposition von artifiziellen transposons mit stumpfen enden
DE29924298U1 (de) Charakterisierung der Genfunktion unter Verwendung doppelsträngiger RNA-Inhibition
DE69612575T2 (de) Hocheffiziente Übersetzung von mRNA Molukülen
DE69031172T2 (de) Modifikation der endogenen genexpression mit hilfe eines regulatorischen elements mittels homologe rekombination
DE69129897T2 (de) Methode des gentransfers mittels retrotransposons
DE3486053T3 (de) Regulierung von Gen-Expression durch Translationshemmung unter Verwendung von m-RNS hinderndem Komplementär-RNS.
DE69918820T2 (de) Dna hochdurchsatzvektor für sequenzierung
EP3353299A1 (de) Verfahren und substanzen zur gerichteten rna-editierung
DE69013495T2 (de) Regulierung der genexpression.
DE60014640T2 (de) Genetische kaskaderegulierte expression von klonierten genen
DE69232768T2 (de) Einzelsträngige hybride DNS-RNS Moleküle und Methoden zur Herstellung
DE3382607T2 (de) Plasmide mit konditionalem unkontrolliertem replikationsverhalten.
EP2228456B1 (de) Selektion kodierender Nukleinsäure-Konstrukte auf Abwesenheit von Frameshift-Mutationen
EP1951870B1 (de) Dna-konstrukte zur spezifischen hemmung der genexpression durch rna-interferenz
EP0093948B1 (de) Doppelstrangiger Vektor und ihn verwendendes Verfahren
DE3431023C2 (enExample)
EP1749096B1 (de) Herstellungsverfahren geeigneter dna-konstrukte zur spezifischen hemmung der genexpression durch rna-interferenz
DE60202196T2 (de) Orientationsgerichtete konstruktion von plasmiden
EP0822258A2 (de) Positiver Selektionsvektor auf Basis des caps-Gens, pCAPs-Vektor und seine Verwendung
EP0299303B1 (de) Eukaryotische Expressionsvektoren mit multimeren Enhancer-Subelementen, Verfahren zu ihrer Herstellung und Verwendung
EP1275736B1 (de) Verfahren zur Identifizierung von Leserastermutationen
DE10119006A1 (de) Verfahren zur Verbesserung der Stabilität linearer DNA in zellfreien in vitro Transkriptions/Translations-Systemen
EP1427822A2 (de) Nukleinsäure für einen klonierungsvektor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition